Literature DB >> 9252545

Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function.

R W Costello1, B H Schofield, G M Kephart, G J Gleich, D B Jacoby, A D Fryer.   

Abstract

Neuronal M2 muscarinic receptors inhibit acetylcholine release from pulmonary parasympathetic nerves but are dysfunctional in antigen-challenged animals and asthmatics. Deletion of pulmonary eosinophils protects M2 receptor function in antigen-challenged guinea pigs. Therefore, the association of eosinophils with airway nerves was investigated. Nerve-associated eosinophils were significantly increased in challenged animals compared with controls (0.75 +/- 0.05 vs. 0.28 +/- 0.05 eosinophils/nerve). In antigen-challenged animals, eosinophil density was greatest around airway nerves, suggesting recruitment to the nerves. M2 receptor function was inversely correlated with the number of eosinophils per nerve, thus eosinophils are associated with airway nerves in antigen-challenged guinea pigs, where they impair M2 receptor function. In airways from three patients with fatal asthma, 196 of 637 eosinophils (30%) were associated with nerves, and release of eosinophil major basic protein was evident; conversely, in three control patients 1 of 11 (9%) eosinophils were in contact with nerves. Thus eosinophils and their granule proteins are also seen in association with airway nerves in patients with asthma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252545     DOI: 10.1152/ajplung.1997.273.1.L93

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  57 in total

1.  Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction.

Authors:  Allison D Fryer; Louis H Stein; Zhenying Nie; Damian E Curtis; Christopher M Evans; Simon T Hodgson; Peter J Jose; Kristen E Belmonte; Erin Fitch; David B Jacoby
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

Review 2.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

Review 3.  Neural control of airway inflammation.

Authors:  Kirsten C Verhein; Allison D Fryer; David B Jacoby
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

4.  Inhibition of neuronal M(2) muscarinic receptor function in the lungs by extracellular nitric oxide.

Authors:  L Golkar; K A Yarkony; A D Fryer
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 5.  The expanding role(s) of eosinophils in health and disease.

Authors:  Elizabeth A Jacobsen; Richard A Helmers; James J Lee; Nancy A Lee
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

6.  Cough in asthma is due to eosinophilic airway inflammation: a pro/con debate.

Authors:  Akio Niimi; Christopher E Brightling; Peter V Dicpinigaitis
Journal:  Lung       Date:  2013-12-14       Impact factor: 2.584

7.  Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.

Authors:  Michael Wagner; Mats Stridsberg; Christer G B Peterson; Per Sangfelt; Maria Lampinen; Marie Carlson
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

8.  Atropine-enhanced, antigen challenge-induced airway hyperreactivity in guinea pigs is mediated by eosinophils and nerve growth factor.

Authors:  Norah G Verbout; David B Jacoby; Gerald J Gleich; Allison D Fryer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

9.  Distribution of major basic protein on human airway following in vitro eosinophil incubation.

Authors:  Ailing Xue; John Wang; Gary C Sieck; Mark E Wylam
Journal:  Mediators Inflamm       Date:  2010-03-22       Impact factor: 4.711

10.  Organophosphorus pesticides decrease M2 muscarinic receptor function in guinea pig airway nerves via indirect mechanisms.

Authors:  Becky J Proskocil; Donald A Bruun; Charles M Thompson; Allison D Fryer; Pamela J Lein
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.